Late CMV Disease after Hematopoietic Cell Transplantation: Significance of Post-Transplant Cyclophosphamide, Steroid Treatment and CMV Viral Load

被引：1
|
作者：
Sadowska-Klasa, Alicja [1 ,2 ]
Ozkok, Sezen [1 ]
Xie, Hu [1 ]
Leisenring, Wendy [1 ,3 ]
Zamora, Danniel [1 ,3 ]
Seo, Sachiko [4 ]
Sheldon, Jordan [1 ]
Lee, Stephanie J. [1 ,3 ]
Green, Margaret L. [1 ,3 ]
Boeckh, Michael [1 ,3 ]
机构：
[1] Fred Hutchinson Canc Ctr, Seattle, WA USA
[2] Med Univ Gdansk, Hematol & Transplantol, Gdansk, Poland
[3] Univ Washington, Seattle, WA 98195 USA
[4] Dokkyo Med Univ, Dept Hematol & Oncol, Shimotsuke, Tochigi, Japan
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180305
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease
    Dioverti, M. Veronica
    Lahr, Brian D.
    Germer, Jeffrey J.
    Yao, Joseph D.
    Gartner, Michelle L.
    Razonable, Raymund R.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (03):
  • [32] The correlation of cytomegalovirus gB genotype with viral DNA load and treatment time in patients with CMV infection after hematopoietic stem cell transplantation
    吴小津
    China Medical Abstracts(Internal Medicine), 2013, 30 (02) : 122 - 122
  • [33] CMV infections after hematopoietic stem cell transplantation
    Ljungman, P.
    BONE MARROW TRANSPLANTATION, 2008, 42 (Suppl 1) : S70 - S72
  • [34] Cytomegalovirus (CMV) disease in peripheral blood (PB) allogeneic hematopoietic cell transplant (HCT) with post transplant cyclophosphamide (PT-Cy).
    Goldsmith, Scott Ryan
    Slade, Michael
    Lawrence, Steven J.
    Romee, Rizwan
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] GVHD PROPHYLAXIS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Storti, G.
    Santoro, L.
    Marano, L.
    De Santis, G.
    Manfra, I.
    Urciuoli, E.
    Marotta, S.
    Frieri, C.
    Cacace, F.
    Pagliuca, S.
    Serio, B.
    D'Addona, M.
    Giudice, V.
    Guariglia, R.
    Palmieri, F.
    Selleri, C.
    Cantore, N.
    Risitano, A. M.
    HAEMATOLOGICA, 2021, 106 (10) : 179 - 180
  • [36] Lower-dose post-transplant cyclophosphamide in haploidentical hematopoietic cell transplantation
    Fuji, Shigeo
    Nakamae, Hirohisa
    Sugita, Junichi
    Najima, Yuho
    Konishi, Tatsuya
    Tanaka, Takashi
    Nakashima, Yasuhiro
    Nishimoto, Mitsutaka
    Okamura, Hiroshi
    Nakayama, Kazutaka
    Ito, Ayumu
    Yoshimitsu, Makoto
    Hino, Masayuki
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Yakushijin, Kimikazu
    BONE MARROW TRANSPLANTATION, 2024, 59 (11) : 1628 - 1630
  • [37] Early toxicities following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide
    Pennisi, Martina
    Mussetti, Alberto
    Sciumbata, Veronica
    Perrone, Giulia
    Corradini, Paolo
    BONE MARROW TRANSPLANTATION, 2018, 53 : 320 - 320
  • [38] NK Cell Immunity Pre-Transplant as a Predictor for CMV Post-Transplant
    Keshwani, S.
    Humar, A.
    Lisboa, L.
    Egli, A.
    Bochud, P.
    Hirsch, H.
    Weisser, M.
    Husain, S.
    Garzoni, C.
    van Delden, C.
    Manuel, O.
    Meylan, P.
    Boggian, K.
    Stern, M.
    Rick, J.
    Mueller, N.
    Kumar, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 178 - 178
  • [39] Clinical utility of cytomegalovirus (CMV) viral load determination for predicting CMV disease in liver transplant recipients
    Humar, A
    Malkan, G
    Caliendo, A
    Gregson, D
    Mazzulli, T
    Krajden, M
    Corey, P
    Greig, P
    Walmsley, S
    Levy, G
    McGeer, A
    TRANSPLANTATION, 1999, 67 (07) : S126 - S126
  • [40] Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients
    Limaye, AP
    Huang, ML
    Leisenring, W
    Stensland, L
    Corey, L
    Boeckh, M
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (03): : 377 - 382
12345